This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Stocks Under $10 Set to Surge

Biocryst Pharmaceuticals

One under-$10 stock that's trending very close to trigger a near-term breakout trade is Biocryst Pharmaceuticals (BCRX), a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. This stock has been in play with the bulls so far in 2013, with shares up 38%.

If you take a look at the chart for Biocryst Pharmaceuticals, you'll notice that this stock has been uptrending for the last month, with shares moving higher from its low of $1.62 to its recent high of $2.09 a share. During that uptrend, shares of BCRX have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of BCRX within range of triggering a near-term breakout trade.

>>5 Health Care Stocks Under $10 to Watch

Traders should now look for long-biased trades in BCRX if it manages to break out above some near-term overhead resistance levels at $2.09 to $2.21 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 1.34 million shares. If that breakout triggers soon, then BCRX will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day of $2.55 a share to $2.88 a share. Any high-volume move above $2.88 will then put $3.25 to $4 into range for shares of BCRX.

Traders can look to buy BCRX off weakness to anticipate that breakout and simply use a stop that sits just below some near-term support levels at $1.85 to $1.70 a share. One can also buy BCRX off strength once it takes out those breakout levels with volume and then simply use a stop that sits just below $1.85 a share.

This stock has a decent amount of bears involved in the name, since the current short interest as a percentage of the float for BCRX is pretty high at 11.8%. We could easily see a large short-squeeze if BCRX breaks out soon, so make sure to put this name on your breakout trading radar.

Make note that Biocryst Pharmaceuticals is set to report earnings next week Tuesday before the market opens. Traders can look to play this breakout ahead of the quarter, or after the quarter, but holding through always holds addition risks.

2 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,086.63 -26.91 -0.16%
S&P 500 1,987.01 +3.48 0.18%
NASDAQ 4,473.6970 +17.6810 0.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs